1. Home
  2. ANY vs IMNN Comparison

ANY vs IMNN Comparison

Compare ANY & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sphere 3D Corp.

ANY

Sphere 3D Corp.

HOLD

Current Price

$0.40

Market Cap

14.7M

Sector

Finance

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$4.06

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANY
IMNN
Founded
N/A
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
12.9M
IPO Year
N/A
1985

Fundamental Metrics

Financial Performance
Metric
ANY
IMNN
Price
$0.40
$4.06
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$3.00
$182.61
AVG Volume (30 Days)
395.3K
33.4K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,099,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$29.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$3.56
52 Week High
$1.32
$41.22

Technical Indicators

Market Signals
Indicator
ANY
IMNN
Relative Strength Index (RSI) 33.11 48.74
Support Level $0.45 $3.83
Resistance Level $0.50 $4.35
Average True Range (ATR) 0.04 0.20
MACD 0.00 0.06
Stochastic Oscillator 3.21 58.54

Price Performance

Historical Comparison
ANY
IMNN

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Share on Social Networks: